#China #Shanghai #Medical Devices #InnoMax MedTech #Jackson Shih

InnoMax MedTech’s Innovative Approach to Medical Device Manufacturing

In recent times, the medical technology sector has witnessed remarkable advancements, and at the forefront is InnoMax Medical Technology Co., Ltd. (InnoMax MedTech), led by visionary Chairman Jackson Shih. At the 2025 Medtec China event held from September 24 to 26, InnoMax exhibited an impressive range of proprietary medical devices, garnering attention from healthcare professionals and industry insiders alike.

Their featured products included a Portable Mesh Nebulizer, a portable oxygen concentrator, an AI-driven sleep-assist device, injection pens, and blood glucose meters. Jackson Shih articulated the company's commitment to transforming the medical device landscape by providing end-to-end services that bridge technical gaps and streamline the development process for clients.

In the backdrop of an evolving industry, Shih highlighted the extensive portfolio of InnoMax, covering key healthcare segments such as in-vitro diagnostics, medical imaging, respiratory care, and wearable health tech. This holistic approach exemplifies their mission as a Contract Development and Manufacturing Organization (CDMO), facilitating comprehensive support across the product lifecycle from conceptual design to final manufacturing.

Shih noted, "The CDMO model has been established successfully in regions like Europe and the United States. However, many domestic companies in China are primarily focused on component processing, leaving a significant gap in full-scale service delivery. This gap can hinder the capabilities of startups and smaller firms who face numerous challenges ranging from funding constraints to technological hurdles."

The challenges that startups encounter often complicate the journey from development to market entry. Shih recognized these obstacles, stating that InnoMax MedTech was founded to mitigate such issues by guiding companies through every phase of the product lifecycle and addressing technical and execution challenges along the way.

Protecting intellectual property is essential for InnoMax’s CDMO partners. Shih explained the company has instituted a comprehensive confidentiality program accompanied by robust technical safeguards covering four core areas: institutional protocols, information security measures, process controls, and personnel management. This multi-layered strategy ensures the safety and privacy of client data, all while preserving the exclusivity of the technologies involved.

Recently, the global CDMO market has experienced substantial growth, with China making strides as a significant player by leveraging its manufacturing advantages, cost efficiencies, and evolving technical prowess. Shih expressed confidence in InnoMax’s capability to deliver integrated solutions for the medical device sector. He stated, "We aspire to deepen our expertise, broaden our international reach, and enhance our service offerings, ultimately providing our clients with more efficient end-to-end solutions that contribute to the development of a world-class, open, and sustainable medical device manufacturing environment."

As the medical technology landscape continues to evolve, InnoMax MedTech's vision under Jackson Shih reflects a promising future where innovation, accessibility, and comprehensive service can coexist to foster growth. Their commitment to addressing the complexities within medical device manufacturing not only aids their clients but ultimately contributes to improved patient care and outcomes globally.